Safety and Effectiveness of Edoxaban in Japanese Venous Thromboembolism Patients　― Final Analysis of One-Year Follow-up Data From a Japanese Postmarketing Observational Study (ETNA-VTE-Japan) ―-Reference-Cited by-同舟云学术

Safety and Effectiveness of Edoxaban in Japanese Venous Thromboembolism Patients　― Final Analysis of One-Year Follow-up Data From a Japanese Postmarketing Observational Study (ETNA-VTE-Japan) ―

Published:2020-03-10 Issue:3 Volume:2 Page:192-202
ISSN:2434-0790
Container-title:Circulation Reports
language:en
Short-container-title:Circ Rep

Author:

Nakamura Mashio¹,Yamada Norikazu²,Asamura Tomohiko³,Shiosakai Kazuhito⁴,Uchino Kazuhiro³

Affiliation:

1. Department of Internal Medicine, Pediatrics and Cardiology, Nakamura Medical Clinic

2. Department of Cardiology, Kuwana City Medical Center

3. Post Marketing Study Department, Daiichi Sankyo Co., Ltd.

4. Clinical Data and Biostatistics Department, Daiichi Sankyo Co., Ltd.

Publisher

Japanese Circulation Society

Subject

Marketing,Organizational Behavior and Human Resource Management,Strategy and Management,Drug Discovery,Pharmaceutical Science,Pharmacology

Link

https://www.jstage.jst.go.jp/article/circrep/2/3/2_CR-19-0127/_pdf

Reference24 articles.

1. 1. Goldhaber SZ, Bounameaux H. Pulmonary embolism and deep vein thrombosis. Lancet 2012; 379: 1835–1846.

2. 2. Sakuma M, Nakamura M, Yamada N, Ota S, Shirato K, Nakano T, et al. Venous thromboembolism: Deep vein thrombosis with pulmonary embolism, deep vein thrombosis alone, and pulmonary embolism alone. Circ J 2009; 73: 305–309.

3. 3. Ota S, Matsuda A, Ogihara Y, Yamada N, Nakamura M, Mori T, et al. Incidence, characteristics and management of venous thromboembolism in Japan during 2011. Circ J 2018; 82: 555–560.

4. 4. Hokusai VTE Investigators, Büller HR, Décousus H, Grosso MA, Mercuri M, Middeldorp S, Prins MH, et al. Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. N Engl J Med 2013; 369: 1406–1415.

5. 5. EINSTEIN Investigators, Bauersachs R, Berkowitz SD, Brenner B, Büller HR, Décousus H, Gallus AS, et al. Oral rivaroxaban for symptomatic venous thromboembolism. N Engl J Med 2010; 363: 2499–2510.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Non-Vitamin K Antagonist Oral Anticoagulants for Japanese Patients With Venous Thromboembolism　― The Primary Results From the KUROSIO Study ―;Circulation Journal;2024-05-28

2. Current Status of Venous Thromboembolism in Japanese;The Japanese Journal of Phlebology;2024-04-27

3. Unapproved Dose of Direct Oral Anticoagulants for Venous Thromboembolism　― Right or Wrong? ―;Circulation Journal;2024-02-22

4. Real-world Safety and Effectiveness of Edoxaban in Patients with Venous Thromboembolism with or without Preceding Parenteral Anticoagulants: A Single-center Retrospective Study;Internal Medicine;2024

5. Comparison of Effectiveness and Safety Among 3 Direct Oral Anticoagulants in Patients With Venous Thromboembolism　― A Single-Center Retrospective Study ―;Circulation Reports;2022-11-10